跳至主要内容
临床试验/EUCTR2012-001859-39-NL
EUCTR2012-001859-39-NL进行中(未招募)不适用

TElmisartan in the management of abDominal aortic aneurYsm (TEDY) - TEDY

eiden University Medical Center0 个研究点目标入组 400 人开始时间: 2012年7月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • AAA measuring a maximum diameter of 35-49 mm on CTA
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 320

排除标准

  • Indication for AAA repair according to the treating physician or expectation that this will be revised within the next year
  • High likelihood of non-compliance with treatment over 24 months
  • Contraindications to study treatment, including: renal impairment (i.e. creatinine >1.5x upper limit of normal [ULN]), known significant renal stenosis (>70%) of one or both renal arteries, chronic liver disease (i.e. cirrhosis or hepatitis) or abnormal liver function (i.e. ALT 1.5xULN), electrolyte imbalance and gout
  • No current or planned usage of an AT1 blocker or ACE inhibitors

研究者

发起方
eiden University Medical Center

相似试验